ImmunomeNasdaq Capital Market: IMNM: Public clinical-stage biotechnology developing targeted oncology therapies for cancer patients.
3+ YOEBSc in molecular biology/biochemistry/biophysics/immunology, 3+ years industry lab experience, mammalian tissue culture, recombinant protein expression/purification, SEC‑UPLC/HIC‑UPLC/DLS/mass spec and BLI/Octet experience, strong documentation skills.
United States or New York City or Vancouver or Switzerland or Serbia
$160k-$260k/yrRemoteFull Time
AbsciNasdaq Global Select Market: ABSI: Public clinical-stage biopharmaceutical using generative AI and synthetic biology to develop antibody therapeutics for patients.
3+ YOEPhD or equivalent in a relevant field, 3+ years of ML and protein design research, Python and PyTorch fluency, AI algorithm expertise, collaboration, communication, and strong publications.
Fred Hutchinson Cancer Center: Independent cancer research and clinical care organization.
Recent PhD and/or MD, productive research record, independent and collaborative research ability, and excellent verbal and written communication skills. Antibody engineering and murine research preferred.
SystImmune: US clinical-stage biopharmaceutical developing bispecific, multispecific antibodies and antibody-drug conjugates for cancer patients.
6+ YOE3+ MgmtPh.D. or equivalent experience in a relevant life science; 6–8+ years biologics industry experience; 3+ years people management; expertise in mammalian expression, antibody purification, and biophysical characterization.
HEK293, CHO, SEC, HPLC/UPLC, CE-SDS, cIEF, DSF/DSC, SPR/BLI, mass spectrometry, ELN/LIMS, liquid handlers, parallel purification systems
RareCyte: Precision biology developing spatial biology and liquid biopsy technologies for researchers, biopharma companies, and clinical programs.
3+ YOEPhD in molecular biology, biochemistry, genetics, or related field; 3+ years industry assay-development experience; antibody assays, immunohistochemistry, immunofluorescence, microscopy, flow cytometry, biostatistics, and Prism experience.
Benaroya Research Institute: Nonprofit human-immunology research institute studying immune-system diseases through laboratory research and clinical trials.
BS/BA in biology, bioengineering, or related field required, plus hands-on biological research laboratory experience. Mammalian cell culture, engineering, flow cytometry, sequencing, or antibody experience is advantageous.
Just-Evotec Biologics, Inc.: Evotec-owned biologics CDMO developing and manufacturing antibodies, biosimilars, and complex biotherapeutics for biopharma partners.
2+ YOEBS in engineering or related field (MS preferred), minimum 2 years industry experience, knowledge of cGMP, monoclonal antibody processing, single-use systems, CQV/commissioning, and strong communication and analytical skills.
SystImmune: US clinical-stage biopharmaceutical developing bispecific, multispecific antibodies and antibody-drug conjugates for cancer patients.
2+ YOEPhD in immunology/cancer biology,2+ years relevant biotech or academic experience,expertise in human immunology,tumor biology,protein therapeutics,mammalian cell culture;bispecific antibody experience preferred,BSL-2 lab experience.
PfizerNYSE: PFE: Multinational pharmaceutical and biotechnology.
Degree in chemistry/biochemistry/chemical engineering or related field; direct experience with antibodies/proteins/bioconjugation; analytical protein characterization (HPLC, IEF, CE-SDS); willingness to work with potent cytotoxics; strong data analysis and communication skills.
Post-Doctoral Research Fellow -Monoclonal Antibodies
Seattle, Washington, United States
$80k-$95k/yrOnsiteFull Time
Fred Hutchinson Cancer Center: Independent cancer research and clinical care organization.
PhD in a quantitative or biomedical field, experience with longitudinal or kinetics modeling, strong communication and teamwork, ability to design and analyze pharmacokinetic studies.
R, Python, RMarkdown, Monolix, Phoenix Modeling & Simulation, NONMEM, SAAM II, SimCyp, GastroPlus, MATLAB, Shiny, Javascript, D3, Git, Github, Docker